Ph.D., Human Physiology, 2000. Chief Scientific Officer, Advanced Restoration Technologies, DBA, HairGenesis®. Representative published research papers include: Prager N., Bickett K., French N., and Marcovici G., A Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Effectiveness of Botanically Derived Inhibitors of 5 alpha-Reductase in the Treatment of Androgenetic Alopecia. J. Alt. & Comp. Med. 8: 143-152. 2002. Chittur, S., Parr, B., Marcovici, G., Inhibition of Inflammatory Gene Expression in Keratinocytes Using a Composition Containing Carnitine, Thioctic Acid and Saw Palmetto Extract (LSESr) 2009, eCAM, doi:10.1093/ecam/nep102.
New University-Based Research Study Demonstrates A Novel Mechanism Of Action For New Hair Formulation, TS050508A
Discovery Could Lead to More Effective Treatments
Dateline: Rensselaer, NY, August 20, 2009
In the current issue of the peer-reviewed medical journal Evidence Based Complimentary & Alternative Medicine (eCAM) scientists at The University of Albany, Center For Functional Genomics, working collaboratively with Advanced Restoration Technologies (ART), report the positive findings of a series of basic science experiments recently undertaken to test a novel, naturally derived hair loss treatment formula, TS050508A.
Because chronic inflammation of the hair follicle is considered a contributing factor in the onset and progression of androgenetic alopecia (AGA), study investigators Sridar Chittur, Brian Parr & Geno Marcovici sought to measure the test material's activity in blocking key markers of pathologic inflammation by using a well-validated molecular assay representative of hair follicle keratinocytes. Specifically, the research team found that the test compound suppressed gene expression of several inflammatory chemokines potentially linked to hair loss.
In addition to anti-inflammatory agents, TS050508A was formulated with a subset of botanically derived, highly potent 5 alpha-reductase (5AR) inhibitors. 5AR catalyzes the conversion of testosterone (T) to its more pathological metabolite dihydrotestosterone (DHT). DHT is a well-known trigger of pattern hair loss. Thus, by combining targeted anti-inflammatory agents with potent 5AR inhibitors the test composition has been designed to offer enhanced clinical efficacy over conventional monotherapy.
Lead scientist for the study Sridar Chittur, Ph.D. has been at the forefront of molecular research authoring published works ranging from degenerative mitral valve disease (DMVD), to transcriptional changes associated with oxidative stress in the mitochondria. Co-author Brian Parr, Ph.D. brings a wealth of basic science expertise to the project with a number of peer-reviewed papers describing novel gene transcription and protein expression profiles in the Wnt and Frizzled pathways.
Study co-author Geno Marcovici, Ph.D. has been active in the hair loss field for more than a decade. His research efforts include the first published clinical trial successfully testing naturally derived 5 alpha reductase inhibitors in the setting of pattern hair loss. Explaining the importance of validating ART's proprietary formulations Marcovici notes that "[a]side from HairGenesis®, the naturally-derived hair treatments commercially available offer little or no objective evidence that they work. On the other hand, the drug-based treatments that do work come with potentially serious negative side effects. This tends to render HairGenesis® a unique proposition in the category. "
About eCAM
With a cited reference impact factor of 2.535, the international, peer-reviewed journal Evidence-based Complementary and Alternative Medicine (eCAM) is widely considered to be among the most well-respected research publications in the ISI category of Integrative & Complementary Medicine. The Journal seeks to apply scientific rigor to the study of complementary and alternative medicine (CAM) modalities. eCAM emphasizes health outcome, while documenting biological mechanisms of action. The journal is devoted to the advancement of science in the field of basic research, clinical studies, methodology or scientific theory in diverse areas of Biomedical Sciences. eCAM is also noteworthy as a journal that makes the final published version of every NIH-funded paper publicly available in PubMed Central no later than 12 months after publication. Such deposits are in accord with the NIH Public Access Policy.
Link To New Hair Growth Formula Study
http://ecam.oxfordjournals.org/cgi/content/full/nep102?ijkey=JY5szXDPsjpHFxm&keytype=ref
About The Center For Functional Genomics, SUNY
The Microarray Core Facility is a component of the University Of Albany Center for Functional Genomics and was established to provide the infrastructure to enable the development of major projects that utilize DNA microarrays for large-scale analysis of gene expression. The DNA Microarray Center currently employs two technologies for gene expression analysis: Affymetrix GeneChip arrays and custom-produced spotted cDNA microarrays. Projects developed through the DNA Microarray Center have made use of Affymetrix arrays from both eukaryotic as well as prokaryotic genomes. The Facility is also currently developing specialized custom printed arrays to examine gene expression in mouse tissues as part of a NIH funded Mutant Mouse Regional Resource Center.
# # #
About Advanced Restoration Technologies Inc., DBA HairGenesis®
Combining scientific validation with the safety of natural ingredients, ART's product line HairGenesis® represents a unique therapeutic platform in the hair loss treatment category. Prior to focusing on basic science research, ART established a 10-year track record as a surgical center for IRB-monitored clinical investigation, testing new drugs as well as medical devices. ART-based published studies include those undertaken on behalf of Organogenesis, Canton, MA and Procyte Corporation, Kirkland, WA. It was from this research platform that Hair Genesis™ was originally conceived and created.
Hair Genesis® is noteworthy as the first, and so far only, naturally derived hair loss treatment supported by published 3rd Party clinical and basic science research. Hair Genesis® is sold primarily through internet-based distribution. Distributors of Hair Genesis® include onlyhairloss.com, hairlosswatch.com, & hairgenesisasia.com.
For more information contact: 
Geno Marcovici, Ph.D. Advanced Restoration Technologies Inc., DBA Hair Genesis® dr.marcovici@hairgenesis.com http://www.hairgenesis.com
- Related Videos
- Related Articles
- Ask / Related Q&A
- What! Female Hair Loss Treatments!
- Hair Growth Products- Hair Dying Tips from the Hair Experts
- Chinese Angelica for natural hair growth and hair regrowth
- How to Grow your Hair and Fight Hair Loss
- Female Hair Loss
- Female Hair Loss Products/treatments
- Female Hair Loss
- Thinning Hair In Women-Stopping Female Hair loss




The Best Hairloss Products Can Help You To Increase Your Hair Growth, Coverage & Confidence
By: Michael P. Myers | 27/11/2009What's the reason you're searching for the best hair loss products on the market today -- is it solely to grow new hair? -- Or is it just as important for you to regain some of the self-confidence you may have lost because of your balding issue.
Can Hair Follicles Be Revived To Reverse Thinning & Balding & Restore Your Hair Back To Good Health
By: Sophie T. Macdonald | 27/11/2009Lots of people experiencing hair thinning, shedding and balding are confused about can hair follicles be revived or not?
How to Grow Hair Faster - Treat the Causes of Hair Loss at the Roots
By: David Curly | 26/11/2009Hair loss is nothing to be alarmed about, and happens to a very high percentage of the population. Still, it can be a frustrating occurrence to contend with. During any time in life, a big cause for hair loss is changes in hormone levels, which means to grow hair faster a man and woman can use hormones to battle their symptoms and grow a lush, healthy head of hair.
Although a Sign of Wisdom Baldness Affects Virility Too
By: Hayden Eck | 26/11/2009Propecia may just be the right cure for you, which effectively treats male pattern baldness. Propecia, a DHT (dihydrotestosterone) inhibitor, and therefore without DHT, hair follicles stop dying and new hair actually grows back.
The Most Advanced Hair Treatment
By: Cherry Bonachita | 26/11/2009Treating your thinning hair or your baldness needs a very deliberate and careful process. You have to choose the safest way of restoring your hair. But before you choose which hair treatment you would like to use, you have to first identify the reason or cause of your hair loss.
Solution to Your Hair Loss
By: Cherry Bonachita | 26/11/2009More often than not, when one reaches the age when hair starts recede and making a person bald, that person loses his or her self-esteem. This is the time when they experience insecurities in their lives and they lose their self confidence. But now
Reasons and Treatment for Hair Loss
By: Cherry Bonachita | 26/11/2009Some are saying that dandruff, constant wearing of hats, lack of vitamins among others are reasons why your head is balding or your hair is thinning. But these reasons have been disproven.
Options 0ffered for Hair Replacements
By: Cherry Bo | 26/11/2009Balding or thinning of hair is but natural for those who have reached the age of thirty and above. This change in the personal appearance of aging men and women is not a problem anymore because there are now treatments which you can choose from in restoring your hair.
New University-Based Research Study Demonstrates A Novel Mechanism Of Action For New Hair Formulation, TS050508A
By: geno marcovici | 11/10/2009 | Hair LossIn the current issue of the peer-reviewed medical journal Evidence Based Complimentary & Alternative Medicine (eCAM) scientists at The University of Albany, Center For Functional Genomics, working collaboratively with Advanced Restoration Technologies (ART), report the positive findings of a series of basic science experiments recently undertaken to test a novel, naturally derived hair loss treatment formula, TS050508A.
Hair Loss and Women's Health
By: geno marcovici | 04/07/2009 | Hair LossAndrogenetic alopecia AGA also known as common pattern hair loss affects approximately 20 million American women. AGA in women is triggered by similar processes to those causing pattern hair loss in men. In both genders, the onset of AGA may occur in early adulthood, though females tend to present signs and symptoms somewhat later than males. From a susceptibility standpoint, the inheritance pattern in female pattern hairloss is polygenic, and the onset and incidence of the disorder closely para
Hair Loss - Myth Vs Fact, Get the Facts Before You Act!
By: geno marcovici | 04/07/2009 | Hair LossCommon pattern hair loss is known to affect over 40 million American men and 20 million American women, yet solid information on the subject can be difficult to obtain. Because hair loss is so widely experienced but widely misunderstood, it is important to separate myth from fact. On this page, we will address common myths and provide factual answers.
Saw Palmetto & Hair Loss, Does it Work?
By: geno marcovici | 04/07/2009 | Hair LossSaw Palmetto & Hair Loss, A Novel Use Of An Intriguing Botanically Derived Ingredient. Androgenetic alopecia, commonly called pattern hair loss shares a striking degree of hormonal factors with other diseases including benign prostatic hyperplasia (BPH). For a number of years, European research studies have pointed to the use of saw palmetto in the setting of BPH. Until recently however, saw palmetto was not considered a particularly valuable tool against hair loss. There are several reasons why
Hair Loss Research, Yesterday, Today & Tomorrow
By: geno marcovici | 04/07/2009 | Hair LossIn years to come, almost no one will be bald. At least not those with reasonable financial means --- and who would prefer to walk through life sporting a full, luxuriant head of hair. So the future, if not rosy, will certainly be quite a bit hairier. The promise of 'essentially' unlimited hair density, while not here today, certainly seems to be looming on the horizon. But when? And how? And, importantly, how much $$? In the following article we will examine these questions and try to provide a